首页> 外文期刊>Revista Brasileira de Anestesiologia >Dexmedetomidina associada a propofol em seda??o durante anestesia local para cirurgia plástica
【24h】

Dexmedetomidina associada a propofol em seda??o durante anestesia local para cirurgia plástica

机译:局部麻醉期间丝绸中右美托咪定与丙泊酚联合使用

获取原文
           

摘要

BACKGROUND AND OBJECTIVES: Dexmedetomidine is a new a2-adrenergic receptor agonist with potentially useful characteristics for anesthesia. This comparative study aimed at evaluating the effects of dexmedetomidine on propofol requirements and cardiovascular/respiratory stability during plastic surgery sedation under local anesthesia. METHODS: Participated in this study 40 female patients aged 16 to 60 years, physical status ASA I or II, scheduled for elective face, nose and breast plastic surgeries under local anesthesia. Patients were randomly allocated into two groups of twenty patients: C (control) and D (dexmedetomidine). Sedation was achieved in both groups with 1 mg.kg-1 bolus propofol followed by continuous infusion at an adjusted rate to provide conscious sedation. Group D patients received continuous intravenous dexmedetomidine at a rate of 0.01 μg.kg-1.min-1, concomitant with propofol infusion. The following were evaluated: effect of dexmedetomidine on propofol requirements; cardiovascular (SBP, DBP, MBP, HR) and respiratory (SpO2, PETCO2) parameters; quality of perioperative bleeding control and postanesthetic recovery features. RESULTS: Mean propofol infusion rate was lower in group D (35.2 ± 5.3 μg.kg-1.min-1) as compared to group C (72.6 ± 8.5 μg.kg-1.min-1). Mean SBP, DBP, MBP values have decreased as from 30 min in group D, remaining stable until procedure completion, while in Group C they have increased. HR remained stable in group D where as increased as from 30 min in group C. Mean time to open eyes under command was lower in group D (6.3 ± 2.5 min) as compared to group C (8.9 ± 2.7 min). Perioperative bleeding control was better in group D as compared to group C. CONCLUSIONS: Dexmedetomidine/propofol association for sedation is safe and has the following advantages: decrease in propofol requirements, cardiovascular stability, good perioperative bleeding control, lack of significant effects on ventilation.
机译:背景与目的:右美托咪定是一种新型的α2-肾上腺素能受体激动剂,具有潜在的麻醉有用特性。这项比较研究旨在评估右美托咪定对局麻下整形手术镇静期间丙泊酚需求量和心血管/呼吸稳定性的影响。方法:参加本研究的40名16至60岁,身体状况为ASA I或II的女性患者,计划在局部麻醉下进行面部,鼻子和乳房整形手术。将患者随机分为两组,每组二十名患者:C(对照组)和D(右美托咪定)。两组均使用1 mg.kg-1的异丙酚推注镇静,然后以调整的速率连续输注以提供清醒镇静作用。 D组患者以0.01μg.kg-1.min-1的速率连续静脉注射右美托咪定,并伴有异丙酚输注。评价了以下内容:右美托咪定对异丙酚需求的影响;心血管(SBP,DBP,MBP,HR)和呼吸(SpO2,PETCO2)参数;围手术期出血质量控制和麻醉后恢复功能。结果:与C组(72.6±8.5μg.kg-1.min-1)相比,D组(35.2±5.3μg.kg-1.min-1)的平均异丙酚输注率较低。从D组的30分钟开始,平均SBP,DBP,MBP值降低,直到手术完成前一直保持稳定,而C组则增加。 D组的HR保持稳定,从C组的30分钟开始增加。与C组(8.9±2.7分钟)相比,D组的平均睁眼时间要短(6.3±2.5分钟)。与C组相比,D组的围手术期出血控制更好。结论:右美托咪定/丙泊酚镇静联合使用是安全的,具有以下优点:减少丙泊酚需求量,心血管稳定性,围手术期良好的出血控制,对通气无明显影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号